Video consultation between cancer patient, general practitioner and oncologist at the start of chemotherapy treatment

Usual care. The patients General Practitioner will receive standard discharge summary and ambulant notes from the oncologist specialist

At the start of the patients chemotherapy treatment a shared video consultation between the patient, general practitioner and oncologist will bee arranged. The video consultation should address distribution of roles, comorbidity, medicine, depression and anxiety symptoms, relatives and social resources.

Shared video consultation between patient, general practitioner and oncologist

Background International guidelines underline the importance of strengthening the coordination and continuity of cancer care. The different roles of general practitioners and oncologists with regard to treatment, follow-up and rehabilitation during and after cancer treatment are often obscure to cancer patients. Parallel courses of healthcare are often taking place instead of coordinated care characterized by continuity and partnership between care providers. Patients may feel uncertain about the health professionals' skills and area of responsibility. Healthcare seeking and support during and after cancer treatment may, therefore, be inappropriate, leaving patients feeling insecure and lost between care providers.The study aims to design and evaluate a new way of communication and shared decision-making that brings the patient, the oncologist and general practitioner together in a shared video-consultation in the early phase of chemotherapeutic treatment. The effect of the intervention in addition to usual care will be tested in a randomized controlled trial at Vejle Hospital in the Region of Southern Denmark. Based on sample size calculation, investigators intent to include 300 patients at the Department of Oncology and their general practitioners. Results and process outcomes will be evaluated qualitatively and quantitatively, questionnaires to patients, general practitioners and oncologists, and data from registers.

Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy

Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy - a Randomized Controlled Trial

Patient reported outcome measure. Cancer patients assessment of their cancer trajectory and their assessment of the cooperation between their General Practitioner and the oncologist specialist.

Patient reported outcome measure. Patients assessment of the cancer disease influence on their daily living.

Patient reported outcome measure. Cancer patients assessment of their quality of life

Patient reported outcome measure. Screening tool and severity measure for generalised anxiety disorder

Patient reported outcome measure.The questionnaire monitor the severity of depression and response to treatment.

It measures the oncologist perception of the benefits with the video consultation intervention. Only the intervention group

It measures the General Practitioners perception of the benefits with the video consultation intervention. Only the intervention group.

It measures the patients perception of the benefits with the video consultation intervention.Only the intervention group

The General Practitioners assessment of the cooperation between the primary and secondary care regarding af specific cancer patient.

National Research Center of Cancer Rehabilitation

Research Unit of General Practice, Odense

Vejle Hospital

Region of Southern Denmark

Odense Patient Data Explorative Network

University of Southern Denmark

MD, PhD fellow

* For the first 90 days, patients alternate between local oncologist and DFCI for weekly visits.
* From 90 to 180 days, patients alternate between local and DFCI every 2-3 weeks.
* Shared Care include the following

  * Formal Care Coordination Plan
  * Patient Engagement and Education
  * Local Oncologist Engagement and Education
  * Patient/Local Oncologist/Transplant Oncologist Web Portal

* Patients receive all follow-up care at DFCI only, which is currently the Standard Care.
* Majority of routine visits in first 180 days will be at DFCI.

Patients receive all follow-up care at DFCI only (Standard Care).

Shared Care involves four specific strategies to allow patients to have a portion of their care locally after HCT, where clinic and laboratory visits are equally shared between the local oncologist and primary HCT team

Shared Care

The usual care provided by the transplant center at DFCI.

Standard Care

Gregory A. Abel, MD MPH

This research study aims to evaluate the effectiveness of allowing patients who have had a hematopoietic cell transplant to receive some of their post-transplant care with a local oncologist rather than returning to the transplant center for all of their follow-up.

Hematopoietic Cell Transplantation (HCT) - also known as bone marrow transplant - is only available at select centers in the United States which can collect and store stem cells, as well as care for patients before their new immune system cells take hold. For this reason, many patients who undergo HCT live at great distances from their HCT center. Also, after hospital discharge, the first 180 days post-HCT are very important, as patients must be managed closely with frequent follow-up visits.

A potential way to make life easier for HCT patients is to allow some of the post-transplant care to be provided by local oncologists who practice closer to where patients live. This could reduce the burden on patients and their caregivers; however, it is not known if a shared care model would ultimately benefit them. The investigators want to assess the effectiveness of a Shared Care program which allows patients to receive half of their post-HCT care at the HCT center, and the other half with their local oncologist

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

Fact-BMT (standard measure of transplant-related quality of life)

EORTC QLQ-C30 (standard measure of cancer-related quality of life)

Dana-Farber post-transplant Survey (questionnaire developed to measure financial hardship after transplant; See Abel, et al BBMT, 2016)

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy	NCT02716168	Cancer	Shared video co...	18 Years -	University of Southern Denmark
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation	NCT03244826	Other Cancer	Shared Care Standard Care	18 Years -	Dana-Farber Cancer Institute

Spots Global Cancer Trial Database for shared care

Every month we try and update this database with for shared care cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for shared care

Every month we try and update this database with for shared care cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for shared care cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.